03:11 , Jan 13, 2018 |  BioCentury  |  Finance

JPM jolt

Fifteen biotechs that presented at the 2018 J.P. Morgan Healthcare Conference posted gains of at least 15%, with Ablynx N.V. (Euronext:ABLX; NASDAQ:ABLX) leading the risers after announcing that its board rejected two unsolicited acquisition proposals...
21:39 , Dec 1, 2017 |  BC Week In Review  |  Clinical News

QIMR reports updated Phase I data for MS candidate

Atara Biotherapeutics Inc. (NASDAQ:ATRA) said QIMR Berghofer Medical Research Institute (Brisbane, Australia) reported updated data from a Phase I trial in 10 patients with primary progressive multiple sclerosis (PPMS) and secondary progressive MS (SPMS) showing...
20:00 , Apr 21, 2017 |  BC Week In Review  |  Clinical News

Autologous ATA188: Interim Ph I data

Interim data from 6 patients with PPMS or SPMS in a Phase I trial showed that 4 escalating doses of autologous ATA188 given over 6 weeks improved MS symptoms in 3 patients as measured by...